List of Qmiiz Odt drug patents

Qmiiz Odt is owned by Tersera.

Qmiiz Odt contains Meloxicam.

Qmiiz Odt has a total of 1 drug patent out of which 0 drug patents have expired.

Qmiiz Odt was authorised for market use on 19 October, 2018.

Qmiiz Odt is available in tablet, orally disintegrating;oral dosage forms.

The generics of Qmiiz Odt are possible to be released after 31 August, 2030.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8545879 TERSERA Fast disintegrating compositions of meloxicam
Aug, 2030

(7 years from now)

Drugs and Companies using MELOXICAM ingredient

Market Authorisation Date: 19 October, 2018

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in